CALL US:022-6101 1700   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Shardul Nautiyal, Mumbai September 20 , 2017
Based on the drug pricing regulator National Pharmaceutical Pricing Authority (NPPA)'s proposed plan to set up a dedicated ceiling price violation cell at Maharashtra Food and Drug Administration (FDA) office last year, the latter is awaiting the funds for the same to kickstart the operations.

The officials heading the cell will report their findings to the NPPA directly in case they find any pharma company violating the law by selling the drugs above the ceiling price.

For this, state government will have to provide space for setting up the office within the state drug regulatory office, as per the plan and the expenditure related to manpower, amenities and other infrastructural cost will be borne by the Centre.

As per the provisions of the law, NPPA will give us certain monetary benefits to set up the cell and is still in the process of allocating a budget on the same, said a senior FDA official.

According to the plan, government has earmarked an amount of Rs. 67 lakh for all category A states in the country of which Rs. 7 lakh has been earmarked for infrastructure and equipment, Rs. 19 lakh for manpower, Rs. 24 lakh for training, Rs. 12 lakh for data collection and sampling and Rs. 5 lakh as contingency fund.

Gujarat, Maharashtra, Karnataka, Andhra Pradesh, Himanchal Pradesh etc fall under the category of A states.

Under the proposed scheme, the cell is to be headed by one person along with a team of NPPA officials whose strength will vary as per the size of the pharma industry in the respective states. NPPA has categorised the states based on three categories, i.e. based on maximum, minimum and least number of pharma cos in the state for better division of work.

In order to effectively detect drug ceiling price violations, Maharashtra Food and Drug Administration (FDA) will be providing an office space for the monitoring cell as planned by the drug regulator. NPPA had discussed and proposed the plan with the state drug regulator to set up a dedicated administrative cell within its office last year.

NPPA held a meeting with all the state drug controllers last year in Delhi to set up price monitoring cells in all the states across the country. With the implementation of the plan, violations reported will be dealt timely with the help of the state NPPA cells in case they find any contravention to the provisions of Drug Price Control Order (DPCO-2013).

Through the price monitoring cells, NPPA will closely work with the state drug regulators to find out any discrepancies that affect the consumers.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
 
Website (required)
CommenT
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
That foods might provide therapeutic benefits is clearly not a new concept. ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)